Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drugfield Pharmaceuticals is a leading privately-held Nigerian pharmaceutical manufacturer founded in 1991 by Olakunle Ekundayo. It operates modern GMP-certified facilities producing over 140 registered products spanning creams, ointments, tablets/capsules, syrups/powders/oral suspensions/injectables—including large volume parenterals—and eye/ear/nasal drops. Its focus is on high-quality affordable generics serving dermatology, infectious disease treatment (especially antibiotics and antifungals), ophthalmology/ENT care among others. The company distributes widely within Nigeria and was the first indigenous Nigerian pharma licensed to market its products in Ghana. There are no indications that it develops novel drug candidates or proprietary platform technologies—it specializes in commercial-scale manufacturing rather than early-stage R&D pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drugfield Pharmaceuticals.